Humacyte Inc is a pioneering biotechnology firm based in Durham, North Carolina, focused on creating revolutionary human tissue replacements. With a strong emphasis on engineering human acellular vessels (HAVs), the company aims to transform treatments for a wide array of medical conditions, including vascular diseases, diabetes, and more. Their innovative HAVs are designed for universal implantation, avoiding immune rejection. Founded in 2004, Humacyte's work spans from vascular repair and hemodialysis access to potential applications in heart surgery and cellular therapy delivery.
On April 18th, 24/7 Wall Street alerted investors to a recent stock purchase by Alabama Senator Tommy Tuberville of a penny stock named Humacyte (Nasdaq: HUMA). We track Congressional trades as sitting members…
Eric Bleeker Tommy Tuberville, a Republican Senator from the state of Alabama, disclosed 19 new stock trades on April 15th, and one trade in particular is causing big movements in the underlying stock. Tuberville…
